MX2007000092A - Azaindoles utiles como inhibidores de proteinas cinasas. - Google Patents

Azaindoles utiles como inhibidores de proteinas cinasas.

Info

Publication number
MX2007000092A
MX2007000092A MX2007000092A MX2007000092A MX2007000092A MX 2007000092 A MX2007000092 A MX 2007000092A MX 2007000092 A MX2007000092 A MX 2007000092A MX 2007000092 A MX2007000092 A MX 2007000092A MX 2007000092 A MX2007000092 A MX 2007000092A
Authority
MX
Mexico
Prior art keywords
compound according
optionally substituted
nitrogen
sulfur
oxygen
Prior art date
Application number
MX2007000092A
Other languages
English (en)
Spanish (es)
Inventor
Guy Brenchley
Michael Mortimore
Francoise Pierad
Juan Miguel Jimenez
Ronald Kengtel
Francesca Mazzei
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/011358 external-priority patent/WO2005103050A2/en
Application filed by Vertex Pharma filed Critical Vertex Pharma
Priority claimed from PCT/US2005/023429 external-priority patent/WO2006004984A1/en
Publication of MX2007000092A publication Critical patent/MX2007000092A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
MX2007000092A 2004-06-30 2005-06-29 Azaindoles utiles como inhibidores de proteinas cinasas. MX2007000092A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58438304P 2004-06-30 2004-06-30
US58472104P 2004-07-01 2004-07-01
PCT/US2005/011358 WO2005103050A2 (en) 2004-04-02 2005-04-04 Azaindoles useful as inhibitors of rock and other protein kinases
US11/098,751 US7514448B2 (en) 2004-04-02 2005-04-04 Azaindoles useful as inhibitors of rock and other protein kinases
PCT/US2005/023429 WO2006004984A1 (en) 2004-06-30 2005-06-29 Azaindoles useful as inhibitors of protein kinases

Publications (1)

Publication Number Publication Date
MX2007000092A true MX2007000092A (es) 2007-03-07

Family

ID=37801682

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007000092A MX2007000092A (es) 2004-06-30 2005-06-29 Azaindoles utiles como inhibidores de proteinas cinasas.

Country Status (4)

Country Link
JP (2) JP5122280B2 (enExample)
IL (1) IL180303A0 (enExample)
MX (1) MX2007000092A (enExample)
NO (1) NO20070502L (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5122280B2 (ja) * 2004-06-30 2013-01-16 バーテックス ファーマシューティカルズ インコーポレイテッド タンパク質キナーゼのインヒビターとして有用なアザインドール
BRPI0515012A (pt) * 2004-08-13 2008-07-01 Genentech Inc substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso
DE102008038221A1 (de) * 2008-08-18 2010-02-25 Merck Patent Gmbh 7-Azaindolderivate
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
ES2734552T3 (es) 2010-04-16 2019-12-10 Ac Immune Sa Compuestos novedosos para el tratamiento de enfermedades asociadas a proteínas amiloides o de tipo amiloide
JP2013529643A (ja) * 2010-06-23 2013-07-22 バーテックス ファーマシューティカルズ インコーポレイテッド Ａｔｒキナーゼ阻害剤として有用なピロロピラジン誘導体
DE102011105469A1 (de) * 2011-06-24 2012-12-27 Merck Patent Gmbh 7-Azaindolderivate
CN107007597A (zh) * 2012-05-31 2017-08-04 菲尼克斯药品股份公司 作为孤儿核受体RORγ调节物的经甲酰胺或磺酰胺取代的噻唑及相关衍生物的制药用途
ES2706306T3 (es) * 2014-02-04 2019-03-28 Taiho Pharmaceutical Co Ltd Derivado de azaindol
WO2022076973A1 (en) * 2020-10-05 2022-04-14 Enliven Therapeutics, Inc. 7-azaindole compounds for inhibition of bcr-abl tyrosine kinases
WO2023110843A1 (en) * 2021-12-15 2023-06-22 Almirall, S.A. Heterobicyclic derivatives as itk inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265403B1 (en) * 1999-01-20 2001-07-24 Merck & Co., Inc. Angiogenesis inhibitors
CA2397661C (en) * 2000-03-01 2012-01-03 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
SE0202463D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
US7514448B2 (en) * 2004-04-02 2009-04-07 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of rock and other protein kinases
JP5122280B2 (ja) * 2004-06-30 2013-01-16 バーテックス ファーマシューティカルズ インコーポレイテッド タンパク質キナーゼのインヒビターとして有用なアザインドール

Also Published As

Publication number Publication date
JP2008513352A (ja) 2008-05-01
NO20070502L (no) 2007-01-26
JP5122280B2 (ja) 2013-01-16
IL180303A0 (en) 2007-06-03
JP2012012417A (ja) 2012-01-19

Similar Documents

Publication Publication Date Title
EP1765819B1 (en) Azaindoles useful as inhibitors of protein kinases
EP1919891B1 (en) 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
EP1919906B1 (en) 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
US7855214B2 (en) Fused cyclic systems useful as inhibitors of TEC family protein kinases
EP2354139A1 (en) Pyrrolopyridines useful as inhibitors of protein kinase
EP2001884A1 (en) Deazapurines useful as inhibitors of janus kinases
EP2318408A2 (en) Tri-cyclic pyrazolopyridine kinase inhibitors
JP2012012417A (ja) タンパク質キナーゼのインヒビターとして有用なアザインドール
CA2731498A1 (en) Tri-cyclic pyrazolopyridine kinase inhibitors
CA2731496A1 (en) Pyrazolopyridine kinase inhibitors
JP2012184260A (ja) 非受容体型チロシンキナーゼのｔｅｃファミリーの阻害剤として有用な３，５−二置換ピリド−２−オン
US20060122213A1 (en) Azaindoles useful as inhibitors of protein kinases
AU2007319786A1 (en) Compounds useful as protein kinase inhibitors
MX2012008642A (es) Inhibidores de cinasas de pirazolopiridinas.
NZ552542A (en) Azaindoles useful as inhibitors of protein kinases
HK1118289A (en) Azaindoles useful as inhibitors of protein kinases
JP2013064015A (ja) タンパク質キナーゼのインヒビターとして有用なアザインドール
HK1156615A (en) Aminopyridine kinase inhibitors

Legal Events

Date Code Title Description
FG Grant or registration